Advertisement
Home »

Gene Expression Profiles Predict Benefit From Neoadjuvant Immune Checkpoint Therapy in Triple-Negative Breast Cancer

Jun 08, 2023

REFERENCES & ADDITIONAL READING

Huebner H, et al. RNA expression levels from peripheral immune cells, a minimal-invasive liquid biopsy source to predict response to therapy, survival and immune-related adverse events in patients with triple negative breast cancer enrolled in the GeparNuevo trial. Abstract 1101. ASCO Annual Meeting 2023, 2–6 June, Chicago.

Lobil S, et al. Ann Oncol. 2019;30:1279-1288.

Lobil A, et al. Ann Oncol. 2022;33:1149-1158

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement